ERBB2 and neoplasm: In addition, we examined tumor killing and T cell proliferation induced by HER2 memAb vs meFab in different conditions—that is, with ET ratios at 1:1, 1:2, or 1:4 and incubation times of 24, 48, or 72 hours (online supplemental figure S9).